Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT SHAPIRO

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1912914318
CMS profile
987590
Location
BURLINGTON, VT

General Payments · PY2018–2024

$70,873.84

  • Reported across 82 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$7,223.26

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $3,137.50 2
Travel and Lodging $3,010.76 9
Education $1,000.00 1
Food and Beverage $75.00 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $4,010.76 10
Amneal Pharmaceuticals LLC $2,950.00 3
ABBVIE INC. $262.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,645.98 6
PY2019 $13,601.35 20
PY2020 $9,050.00 5
PY2021 $10,993.75 4
PY2022 $14,482.03 23
PY2023 $11,877.47 10
PY2024 $7,223.26 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $262.50 11/12/2024 Consulting Fee Undisputed 01/23/2026 1106073514 CMS
Amneal Pharmaceuticals LLC $40.00 06/13/2024 Food and Beverage Undisputed 01/23/2026 1139201760 CMS
Amneal Pharmaceuticals LLC $35.00 06/13/2024 Food and Beverage Undisputed 01/23/2026 1139201762 CMS
Amneal Pharmaceuticals LLC $2,875.00 06/13/2024 Consulting Fee Undisputed 01/23/2026 1139201764 CMS
Lilly USA, LLC $911.55 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1135359496 CMS
Lilly USA, LLC $181.17 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1135359498 CMS
Lilly USA, LLC $180.02 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1135359500 CMS
Lilly USA, LLC $181.17 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1135368470 CMS
Lilly USA, LLC $180.02 04/13/2024 Travel and Lodging Undisputed 01/23/2026 1135371076 CMS
Lilly USA, LLC $142.00 06/15/2024 Travel and Lodging Undisputed 01/23/2026 1135355586 CMS
Lilly USA, LLC $175.10 06/15/2024 Travel and Lodging Undisputed 01/23/2026 1135368468 CMS
Lilly USA, LLC $878.63 06/15/2024 Travel and Lodging Undisputed 01/23/2026 1135371074 CMS
Lilly USA, LLC $181.10 06/15/2024 Travel and Lodging Undisputed 01/23/2026 1135393473 CMS
Lilly USA, LLC $1,000.00 06/15/2024 Education Undisputed 01/23/2026 1135394189 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.